![](/img/cover-not-exists.png)
Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non–small cell lung cancer (WJOG 5910L)
Masayuki Takeda, Isamu Okamoto, Takeharu Yamanaka, Kazuhiko Nakagawa, Yoichi NakanishiVolume:
12
Language:
english
DOI:
10.1186/1471-2407-12-327
Date:
December, 2012
File:
PDF, 149 KB
english, 2012